290
Views
3
CrossRef citations to date
0
Altmetric
Research Reports

MERTK retinopathy: biomarkers assessing vision loss

, , MBBSORCID Icon, , , PhD, FRANZCOORCID Icon, , , BMSci, MOrth, , , BHSci, MOrth, , , BForBiol, MOrth, , , MBBS, FRACP, , , MBBS, FRACP, , , MBBS, FRACP, , , MD, FRANZCOORCID Icon, , , BMedSci, , , PhD, FRACPORCID Icon & , , MD, FRANZCOORCID Icon show all
Pages 706-716 | Received 30 Apr 2021, Accepted 09 Jul 2021, Published online: 22 Jul 2021
 

ABSTRACT

Purpose

Mer tyrosine kinase-retinitis pigmentosa (MERTK-RP) causes a primary defect in the retinal pigment epithelium, which subsequently affects rod and cone photoreceptors. The study aims to identify the most appropriate MERTK-RP biomarkers to measure disease progression for deciding the optimum therapeutic trial intervention time.

Materials and Methods

Patients’ data from baseline (BL) and last follow-up (LFU) were reviewed. Best corrected visual acuity (BCVA), spectral domain-optical coherence tomography (SD-OCT), ultra-widefield fundus autofluorescence (UWF-FAF) patterns, kinetic perimetry (KP), and electroretinography (ERG) parameters were analyzed.

Results

Five patients were included with the mean age of 17.7 ± 14.4 years old (6.7–42.3) at BL and mean BCVA follow-up of 8.4 ± 5.1 years. Mean BCVA at BL and LFU were 0.84 ± 0.86 LogMAR and 1.14 ± 0.86 LogMAR, respectively. The BCVA decline rate was 0.05 ± 0.03 LogMAR units/year. Ellipzoid zones (EZ) were measurable in eight eyes with mean BL length of 1293.75 ± 421.07 µm and reduction of 140.95 ± 69.28 µm/year and mean BL CMT of 174.2 ± 37.52 µm with the rate of 11.2 ± 12.77 µm declining/year. Full-field ERG (ffERG) and pattern ERG (pERG) were barely recordable. UWF-FAF showed central macular hyper-autofluorescence (hyperAF). KP (III4e and V4e) was normal in two eyes, restricted nasally in four eyes, superior wedge defect in two eyes and undetectable in two eyes. The four restricted nasally KPs became worse, while the others stayed almost unchanged.

Conclusions

This cohort showed early visual loss, moderately rapid EZ reduction and macular hyperAF. EZ, CMT, and BCVA were consistently reduced. Relative rapid decline in these biomarkers reflecting visual function suggests an early and narrow timespan for intervention.

Acknowledgements

The authors would like to thank Dr Maria Korsakova, Dr Nonna Saakova and Ms Haipha Ali for electrophysiology testing and assessment. DHS also would like to thank Indonesia Endowment Fund for Education (LPDP) for the scholarship.

Disclosure of Interest

D.H Sakti, None; E.E Cornish, None; N. Mustafic, None; A. Zaheer, None; S. Retsas, None; S. Rajagopalan, None; C.W.T Chung, None; L. Ewans, None; P. McCluskey, None; B. M Nash; R.V Jamieson, Novartis (C); J. R Grigg, Novartis (C).

Additional information

Funding

This study was partly funded by National Health and Medical Research Council (NHMRC) Grants APP1116360, APP1099165, APP1109056 and Ophthalmic Research Institute of Australia (ORIA).The funding organization had no role in the design or conduct of this research.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 691.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.